Most guideline updates don't really matter for parents — they adjust language a clinician was using anyway. This one actually changes things. Three differences worth knowing about.
1. GPs can now initiate ADHD care in more states
The new guideline supports expanded GP prescribing authority for stable, uncomplicated ADHD, in line with state-level changes already underway in NSW, SA, and Queensland. This doesn't mean a GP will diagnose your child out of a fifteen-minute appointment — initial diagnosis still requires a paediatrician or psychiatrist. But ongoing medication management is increasingly something your GP can handle, which shortens review waits and lowers cost.
Practically: once your child is stable on medication, you may see fewer paediatrician follow-ups and more GP-led reviews. That's the intent, and it's a good thing for access.
2. Psychosocial supports are now listed alongside medication, not after it
Previously the guideline framed medication as the first-line treatment with psychosocial supports as adjunct. The new version lists them as parallel — both are expected, both are core. Parent training, behavioural strategies, school collaboration, and occupational therapy aren't optional extras. They're part of best-practice care.
This matters because it gives you more leverage when a paediatrician offers medication alone. The guideline now explicitly supports a broader package.
3. Broader recognition of the inattentive presentation
The guideline now names the inattentive presentation — often girls, often missed until adolescence — as an area of particular concern and reviews the evidence for earlier identification. Clinicians are explicitly directed to screen for the quieter pattern, not only the classroom-disruptive one.
What to do with this
If you're in the diagnostic queue, raise pre-diagnostic supports with your GP — the new guideline backs you on this. If your child is already diagnosed and stable, ask whether GP-led reviews are viable in your state. And if your child's current care is medication-only, the guideline now explicitly supports a broader package — raise it at the next review.
This post was reviewed by Dr. James Okafor, Paediatrician, before publish. We don't publish health writing without an AHPRA-registered clinician reading it first.